" Osteopore provides this page to help educate patients, clinicians and researchers about the rationale for the design of our products."
All of our products are developed using state-of-the-art technology and adhere strictly to international quality standards with the ultimate goal of creating safer and more effective clinical solutions.
Osteopore is recognized globally and is a manufacturer for new engineering innovations for medical applications of tomorrow. In the present climate of increasing life expectancy with a resultant increase in bone-related injuries, orthopaedic, plastic and reconstructive surgery are undergoing a paradigm shift from standard bone grafting to tissue engineering, where a scaffold is implanted to provide sufficient load-bearing support and regenerate tissue. In 1999, a team of Singapore engineers and clinicians designed a technological platform for the manufacturing of novel 3-dimensional (3D) scaffolds, which marked the beginning of Osteopore.
At Osteopore, our products are fabricated in-house using 3D printing technology that is precise and allows for customisation of shape and geometry. This is critical for establishing a snug fit with the human anatomy. The unique architecture of our products is conducive for infiltration of cells and blood vessels, both of which play key roles in wound healing and tissue repair. Osteopore products are made of a US Food and Drug Administration (FDA)-approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possess mechanical strength similar to trabecular bone. Our products have no known undesirable side-effects in experimental animal subjects and human participants.